{"product_id":"sr-9011-gw-0742","title":"SR-9011 + GW-0742","description":"\u003ch2\u003e\u003cspan\u003eSR-9011 (REV-ERB Agonist) + GW-0742 (Fitorine) | Metabolic Research UK\u003c\/span\u003e\u003c\/h2\u003e\n\u003ch2\u003e\u003cspan\u003eEnergy Metabolism Research Set\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eThe BioPlex Energy Metabolism Research Set combines SR-9011 (REV-ERB Agonist) 50×15mg and GW-0742 (Fitorine) 50×15mg, bringing together two synthetic research compounds associated with distinct nuclear-receptor pathways involved in metabolic and cellular-energy research. The set contains one pot of each compound and provides a structured format for comparative laboratory investigation of REV-ERB-associated signalling alongside PPARδ-associated research.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eSR-9011 is associated primarily with experimental investigation of REV-ERBα and REV-ERBβ. These nuclear receptors participate in transcriptional networks linking circadian regulation with metabolic processes, making them important targets in research examining the relationship between biological timing, gene expression and cellular metabolism.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eGW-0742 represents a separate molecular pathway. Presented within the BioPlex range as Fitorine, GW-0742 is associated primarily with peroxisome proliferator-activated receptor delta, commonly abbreviated PPARδ. Research involving this receptor has examined transcriptional pathways associated with lipid handling, fatty-acid metabolism and cellular-energy regulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eNeither SR-9011 nor GW-0742 is scientifically classified as a selective androgen receptor modulator. Although compounds of this type may appear commercially alongside SARMs, their molecular targets and pharmacological classifications are different from androgen-receptor ligands such as RAD-140 or MK-2866.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eThe Energy Metabolism Research Set therefore creates a two-pathway laboratory research format rather than pairing compounds with an identical molecular target.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eEach compound remains individually identified, enabling researchers to investigate REV-ERB and PPARδ-associated pathways independently while comparing predefined metabolic and transcriptional endpoints within a controlled research framework.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003eHow SR-9011 and GW-0742 Work Together\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eSR-9011 and GW-0742 provide an interesting comparative research pairing because each is associated with a different nuclear-receptor system connected with metabolic regulation. SR-9011 is associated with REV-ERB research, whereas GW-0742 is associated primarily with PPARδ.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eREV-ERBα and REV-ERBβ participate in the molecular machinery responsible for circadian transcriptional regulation. Circadian biology extends beyond the sleep-wake cycle and involves rhythmic changes in gene expression across numerous cellular and metabolic processes. This has made REV-ERB signalling an important area of experimental investigation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eSR-9011 has been used as a synthetic research compound within this field, allowing researchers to investigate relationships between REV-ERB-associated signalling, circadian transcription and predefined metabolic markers.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eGW-0742 provides a different research mechanism. PPARδ belongs to the nuclear-receptor superfamily and participates in transcriptional regulation of pathways involving lipid utilisation, fatty-acid metabolism and cellular-energy processes.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003ePlacing these two compounds within the same research set therefore allows researchers to consider two distinct transcriptional systems within a broader energy-metabolism framework.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eThe combination does not establish that SR-9011 and GW-0742 act synergistically. Nor does activity involving one receptor system demonstrate that the other pathway will respond in a particular manner. Cellular metabolism is controlled through interconnected regulatory networks, and experimental outcomes can vary according to model, concentration, receptor expression, exposure and methodology.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eThe research value instead comes from pathway comparison. SR-9011 provides the REV-ERB-associated component, while GW-0742 provides the PPARδ-associated component.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eThis creates a structured format for investigating different aspects of metabolic transcriptional regulation while maintaining appropriate compound-specific controls and scientifically accurate classification.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003eSR-9011 (REV-ERB Agonist) 50×15mg\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eSR-9011 is a synthetic research compound associated with experimental investigation of the nuclear receptors REV-ERBα and REV-ERBβ. It has been used within research examining circadian transcription, metabolic regulation and the molecular relationship between biological timing and cellular processes.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eREV-ERB receptors belong to the nuclear-receptor superfamily and participate in transcriptional networks forming part of the molecular circadian clock. Their regulatory activity connects circadian biology with broader areas of metabolism and gene expression.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eThis relationship has generated scientific interest in synthetic ligands capable of experimentally influencing REV-ERB-associated pathways. SR-9011 has consequently been investigated in experimental systems examining metabolic, transcriptional and circadian-associated endpoints.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eHowever, classification as a REV-ERB-associated research compound does not mean that every observed experimental response can automatically be attributed exclusively to REV-ERB signalling. Compound concentration, cellular environment, experimental model and potential off-target activity must be considered when interpreting findings.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eSR-9011 is also not a SARM. Its principal research classification concerns REV-ERB-associated nuclear-receptor biology rather than selective modulation of the androgen receptor.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eWithin the Energy Metabolism Research Set, SR-9011 provides the circadian and REV-ERB-associated component of the pairing.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eThis can be investigated independently before predefined observations are compared with the PPARδ-associated research profile of GW-0742.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eMaintaining this distinction is important because both compounds may be grouped commercially within broader research-compound categories despite having different molecular targets.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eSR-9011 therefore contributes a distinct transcriptional research pathway to the set, supporting comparative investigation of metabolic signalling without treating different classes of research compounds as pharmacologically interchangeable.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003eGW-0742 (Fitorine) 50×15mg\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eGW-0742, presented within the BioPlex research range as Fitorine, is a synthetic research compound associated primarily with peroxisome proliferator-activated receptor delta, commonly abbreviated PPARδ.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003ePPARδ belongs to the nuclear-receptor superfamily and functions as a transcriptional regulator. Research involving this receptor has examined gene-expression pathways associated with lipid handling, fatty-acid metabolism, cellular-energy regulation and related areas of metabolic biology.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eGW-0742 has consequently been used experimentally as a pharmacological research tool for investigating PPARδ-associated signalling and determining how receptor modulation corresponds with changes in predefined molecular and cellular endpoints.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eIts molecular classification clearly distinguishes it from SR-9011. Although both compounds can be studied within the broad field of metabolic regulation, SR-9011 is associated with REV-ERB research whereas GW-0742 provides the PPARδ-focused component.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eGW-0742 is also not a selective androgen receptor modulator. Its inclusion within commercial research-compound ranges alongside SARMs should not be interpreted as evidence of androgen-receptor activity.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eWithin the Energy Metabolism Research Set, GW-0742 therefore provides a complementary but mechanistically distinct research pathway.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eResearchers can investigate PPARδ-associated observations independently before comparing selected metabolic and transcriptional markers with those generated within SR-9011 experimental systems.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eThis approach preserves the pharmacological identity of each compound rather than assuming that shared relevance to metabolic research means identical biological activity.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eConcentration, exposure, receptor expression, cellular environment and potential off-target effects remain important considerations when interpreting experimental findings.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eTogether with SR-9011, GW-0742 creates a two-compound framework for comparative investigation of nuclear-receptor pathways associated with metabolic and cellular-energy research.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003e\u003cbr\u003eExplore Related Research Compounds\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eContinue exploring related metabolic and nuclear-receptor research compounds from the BioPlex capsule range.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003ca href=\"https:\/\/bioplexpeptides.co.uk\/collections\/sarms\" title=\"SR-9011 REV-ERB Agonist | Metabolic Research Capsules | BioPlex UK\"\u003e\u003cspan\u003eView SR-9011 REV-ERB Agonist 50×15mg Research Capsules ⟶\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003ca href=\"https:\/\/bioplexpeptides.co.uk\/collections\/sarms\" title=\"GW-0742 Fitorine | PPARδ Research Compound | BioPlex UK\"\u003e\u003cspan\u003eView GW-0742 Fitorine 50×15mg Research Capsules ⟶\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003ca href=\"https:\/\/bioplexpeptides.co.uk\/collections\/sarms\" title=\"SR-9009 Stenabolic | Metabolic Research Capsules | BioPlex UK\"\u003e\u003cspan\u003eView SR-9009 Stenabolic 50×15mg Research Capsules ⟶\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003e\u003cbr\u003eExplore BioPlex Research Information\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eAccess BioPlex research guidance, compound classification and the complete research product range.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003ca href=\"https:\/\/bioplexpeptides.co.uk\/blogs\/sarms-research-articles-bioplex-peptides-uk\/science-research-studies-complete-guide-to-sarms-uk-research-compounds-explained-for-2026\" title=\"Complete SARMs UK Research Compound Guide 2026 | BioPlex Peptides\"\u003e\u003cspan\u003eRead the Complete SARMs UK Research Compound Guide ⟶\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003ca href=\"https:\/\/bioplexpeptides.co.uk\/collections\/sarms\" title=\"SARMs \u0026amp; Research Compounds UK | BioPlex Peptides\"\u003e\u003cspan\u003eExplore the BioPlex SARMs \u0026amp; Research Compound Range ⟶\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003ca href=\"https:\/\/bioplexpeptides.co.uk\/collections\/all-products\" title=\"All Research Products UK | Peptides, SARMs \u0026amp; Solutions | BioPlex Peptides\"\u003e\u003cspan\u003eView All BioPlex Research Products ⟶\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003e\u003cbr\u003eExplore Related Research Articles\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eContinue your research with BioPlex articles covering metabolic research compounds, nuclear-receptor signalling and the scientific classification of compounds sold alongside SARMs.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003ca href=\"https:\/\/bioplexpeptides.co.uk\/blogs\/sarms-research-articles-bioplex-peptides-uk\/science-research-studies-complete-guide-to-sarms-uk-research-compounds-explained-for-2026\" title=\"SR-9011 GW-0742 Research Compound Classification | BioPlex Peptides\"\u003e\u003cspan\u003eRead the Complete SARMs UK Research Compound Guide ⟶\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003ca href=\"https:\/\/bioplexpeptides.co.uk\/blogs\/sarms-research-articles-bioplex-peptides-uk\" title=\"SARMs \u0026amp; Research Compound Articles | BioPlex Peptides UK\"\u003e\u003cspan\u003eExplore All BioPlex SARMs Research Articles ⟶\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan\u003e\u003cbr\u003eDisclaimer\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/bioplexpeptides.co.uk\/policies\/legal-notice\" title=\"Legal Notice | BioPlex Peptides UK\"\u003e\u003cspan\u003eFor research purposes only. Not for human consumption\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"BioPlexPeptides.co.uk","offers":[{"title":"Default Title","offer_id":58756320592256,"sku":null,"price":89.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0991\/6783\/0400\/files\/SR-9011_GW-0742.png?v=1787440860","url":"https:\/\/bioplexpeptides.co.uk\/es\/products\/sr-9011-gw-0742","provider":"BioPlexPeptides.co.uk","version":"1.0","type":"link"}